- Home
- / MitoRx Therapeutics
MitoRx Therapeutics
Total Funding
$4 M
MitoRx Therapeutics Summary
Company Summary
- Overview
- MitoRx Therapeutics is a biotechnology company that specializes in degenerative disease treatment solutions. It develops therapies that reverse mitochondrial dysfunction in neuromuscular, metabolic, and neurodegenerative diseases.
- Type
- Private
- Status
- Active
- Founded
- 2021
- HQ
- Oxford, GB | view all locations
Table of Contents
Key People
Norman Law, CTO, Co-Founder and Head of IP
Christine Charman, Chief Developmant Officer
Matt Whiteman, CSO and Co-Founder
LocationsView all
2 locations detected
Oxford, England HQ
United Kingdom
9400 Garsington Road, Oxford Business Park
Exeter, England
United Kingdom
The Innovation Centre University Of Exeter, Rennes Drive